METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Clinical trials for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial is testing new combinations of experimental cancer drugs in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and understand how the drugs work in the body. Researchers will also look for…
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug enters first human safety tests
Disease control OngoingThis is a first-in-human, early-stage study to find a safe dose and understand how the body processes a new cancer drug called tuvusertib. It is testing the drug alone and in combination with another cancer drug, niraparib, in about 161 people with advanced solid tumors that have…
Matched conditions: METASTATIC OR LOCALLY ADVANCED UNRESECTABLE SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC